Diabetes: Cost of illness in Norway

BMC Endocrine Disorders

Volumn 10, Issue , 2010, Pages

  Solli, Oddvar ^a   Jenssen, Trond ^b,c   Kristiansen, Ivar S ^a,d  

^a Department of Health Management and Health Economics ^*  (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYPOCHOLESTEROLEMIC AGENT; INSULIN DERIVATIVE; ORAL ANTIDIABETIC AGENT;

ACUPUNCTURE; ARTICLE; DIET THERAPY; HEALTH CARE COST; HEALTH INSURANCE; HOSPITAL ADMISSION; HOSPITAL SERVICE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MEDICAL INSTRUMENTATION; MEDICAL LEAVE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; PHYSIOTHERAPY;

EID: 77956631503     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-10-15     Document Type: Article

References (23)

1. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998, 317:703-713. 28659, 9732337, UK Prospective Diabetes Study Group.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16:434-444. 10.2337/diacare.16.2.434, 8432214.
3. Henriksson F, Jonsson B. Diabetes: the cost of illness in Sweden. Journal of Internal Medicine 1998, 244:461-468. 10.1111/j.1365-2796.1998.00388.x, 9893099.
4. Henriksson F, Agardh CD, Berne C, Bolinder J, Lonnqvist F, Stenstrom P, Ostenson CG, Jonsson B. Direct medical costs for patients with type 2 diabetes in Sweden. Journal of Internal Medicine 2000, 248:387-396. 10.1046/j.1365-2796.2000.00749.x, 11123503.
5. Jonsson B. Diabetes--the cost of illness and the cost of control. An estimate for Sweden 1978. Acta Med Scand Suppl 1983, 671:19-27.
6. Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053. 10.2337/diacare.27.5.1047, 15111519.
7. Midthjell K, Kruger O, Holmen J, Tverdal A, Claudi T, Bjorndal A, Magnus P. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trondelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care 1999, 22:1813-1820. 10.2337/diacare.22.11.1813, 10546013.
8. Stene LC, Midthjell K, Jenum AK, Skeie S, Birkeland KI, Lund E, Joner G, Tell GS, Schirmer H. [Prevalence of diabetes mellitus in Norway]. Tidsskr Nor Laegeforen 2004, 124:1511-1514.
9. The Norwegian Prescription Database. , http://www.norpd.no
10. Midthjell K. [Diabetes in adults in Nord-Trøndelag. Epidemiological and public health aspects of diabetes mellitus in a large, non-selected Norwegian population]. Phd-Thesis 2001, The Norwegian University of Science and Technology (NTNU).
11. Strom H, Engeland A, Eriksen E, Sakshaug S, Ronning M. [How many and who are receiving medication for diabetes mellitus?]. Tidsskr Nor Laegeforen 2006, 126:768-770.
12. American Diabetes Association Economic Costs of Diabetes in the U.S. in 2002. Diabetes Care 2003, 26:917-932. 10.2337/diacare.26.3.917, 12610059, American Diabetes Association.
13. American Diabetes Association Economic Costs of Diabetes in the U.S. in 2007. Diabetes Care 2008, 31:596-615. 10.2337/dc08-9017, 18308683, American Diabetes Association.
14. Dawson KG, Gomes D, Gerstein H, Blanchard JF, Kahler KH. The Economic Cost of Diabetes in Canada, 1998. Diabetes Care 2002, 25:1303-1307. 10.2337/diacare.25.8.1303, 12145225.
15. Koster I, von Ferber L, Ihle P, Schubert I, Hauner H. The cost burden of diabetes mellitus: the evidence from Germany - the CoDiM Study. Diabetologia 2006, 49:1498-1504. 10.1007/s00125-006-0277-5, 16752168.
16. Hart WM, Espinosa C, Rovira J. A simulation model of the cost of the incidence of IDDM in Spain. Diabetologia 1997, 40:311-318. 10.1007/s001250050680, 9084970.
17. Fee Schedule for general practice (in Norwegian: Fastlegetariffen, Normaltariff). 2005. 2005, Norwegian Medical Assosiation, Oslo.
18. Statistics Norway 2008, Statistics Norway., http://www.ssb.no/helsesat/arkiv/art-2006-05-30-01.html
19. SINTEF 2008, SINTEF., http://www.sintef.no/project/Samdata/rapporter/Sykehusbruk_blant_eldre_i_Skandinavia_i_2002_rapport_STF78_A055015.pdf
20. Jonsson L, Bolinder B, Lundkvist J. Cost of hypoglycemia in patients with Type 2 diabetes in Sweden. Value Health 2006, 9:193-198. 10.1111/j.1524-4733.2006.00100.x, 16689714.
21. Ettaro L, Songer TJ, Zhang P, Engelgau MM. Cost-of-illness studies in diabetes mellitus. PHARMACOECONOMICS 2004, 22:149-164. 10.2165/00019053-200422030-00002, 14871163.
22. Nolan JJ, O'Halloran D, McKenna TJ, Firth R, Redmond S. The cost of treating type 2 diabetes (CODEIRE). Ir Med J 2006, 99:307-310.
23. Bolin K, Gip C, Mörk A-C, Lindgren B. Diabetes, healthcare cost and loss of productivity in 1987 and 2005 - a register-based approach. Diabetic Medicine 2009, 26:928-934. 10.1111/j.1464-5491.2009.02786.x, 19719715.